Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
734 studies found for:    osteoporosis AND (woman OR women OR female)
Show Display Options
Rank Status Study
21 Completed PTH Comparison in Post Menopausal Women
Condition: Osteoporosis, Post-Menopausal
Interventions: Drug: teriparatide 20 micrograms/day subcutaneous;   Drug: calcitonin 100 IU/day subcutaneous
22 Completed Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: Raloxifene HCL;   Drug: Placebo
23 Completed Safety and Efficacy of AAE581 in Postmenopausal Women With Osteoporosis
Condition: Osteoporosis
Intervention: Drug: AAE581
24 Completed
Has Results
A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP)
Condition: Postmenopausal Osteoporosis
Intervention: Drug: Ibandronate
25 Completed Dose Ranging Study - Macroflux PTH in Postmenopausal Women With Osteoporosis
Condition: Osteoporosis
Intervention: Drug: teriparatide
26 Completed A Randomized Phase 3 Study to Evaluate 2 Different Formulations of Romosozumab in Postmenopausal Women With Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: Romosozumab;   Drug: Placebo
27 Completed A Study of Arzoxifene to Treat Korean Women With Osteoporosis
Condition: Osteoporosis
Interventions: Drug: arzoxifene;   Drug: Placebo
28 Completed A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: Denosumab (CP2);   Drug: Denosumab (CP4)
29 Completed Drug Holidays in the Treatment With Alendronate in Postmenopausal Women With Osteoporosis
Condition: Osteoporosis
Intervention: Drug: alendronate
30 Completed Study of PH3 for the Prevention of Osteoporosis in Postmenopausal Women
Condition: Osteoporosis
Intervention: Drug: PH3
31 Completed Study With AMG 785 to Treat Japanese Women With Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis (PMO)
Interventions: Drug: AMG 785;   Drug: Placebo
32 Completed
Has Results
A Study to Test the Effect of MK0217A on Vitamin D Inadequacy in Postmenopausal Women With Osteoporosis (0217A-262)
Condition: Osteoporosis
Interventions: Drug: FOSAVANCE 5600 (Alendronate Sodium (+) cholecalciferol);   Dietary Supplement: Calcium Supplement 500 mg;   Other: Referred-Care Model
33 Completed
Has Results
Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis
Condition: Osteoporosis
Interventions: Drug: teriparatide;   Drug: Placebo;   Drug: BA058 20 µg;   Drug: BA058 40 µg;   Drug: BA058 80 µg
34 Completed Efficacy & Safety of ViaDerm-hPTH(1-34) Compared to Forteo SC in Postmenopausal Women With Osteoporosis
Condition: Osteoporosis
Intervention: Drug: Teriparatide
35 Completed Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal Women
Conditions: Osteoporosis;   Bone Loss, Age Related;   Postmenopausal Bone Loss;   Postmenopausal Osteoporosis
Intervention: Behavioral: Osteoporosis Choice Decision Aid
36 Terminated
Has Results
A Dose-Ranging Study of MK-5442 in Postmenopausal Women With Osteoporosis (MK-5442-001)
Condition: Osteoporosis
Interventions: Drug: MK-5442;   Drug: Placebo;   Dietary Supplement: Vitamin D3;   Dietary Supplement: Calcium carbonate
37 Completed Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: teriparatide;   Drug: Placebo;   Drug: Calcium Supplement;   Drug: Vitamin D Supplement
38 Active, not recruiting Teriparatide (PTH) and Bone Strength in Postmenopausal Women
Condition: Osteoporosis
Intervention: Drug: Forteo
39 Terminated A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.
Condition: Osteoporosis
Interventions: Drug: Ronacaleret;   Drug: Teriparatide;   Drug: Alendronate
40 Completed Improved Screening for Osteoporosis
Condition: Osteoporosis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.